The Financial Times' 'Stockpickers' column mentions Oxford Nanopore Technologies as a company to analyze for potential buying, selling, or holding. News surrounding the company includes its CEO's upcoming departure after two decades, and the company admitting it is a takeover target. Analysts predict that Oxford Nanopore Technologies is three years away from breaking even.
Previously, Oxford Nanopore shares surged over 40% during its London IPO. The company also secured a $50 million investment from Amgen and reached a valuation of $1.5 billion after tapping Asia-Pacific funding. The chairperson of Oxford Nanopore Technologies has reportedly boosted their holding in the company, indicating confidence in its future.
